In the Margins
Concentrated bets on individual stocks raise issues for mutual funds and their investors—a matter highlighted last week at Sequoia Fund, one of the biggest investors in controversial drug maker Valeant Pharmaceuticals International Inc. Placing outsize bets on well-chosen stocks can lead to strong performance, but concentration increases the riskiness of a fund and raises questions about how much is too much. Read the original story from The Wall Street Journal.
Most Read
Independent mutual fund directors took home more money in 2018, and the boards on which they sit became slightly more diverse, according to new data published ...
Long-serving independent director Dorothy Berry has died at 75. She was independent chair of Professionally Managed Portfolios and an independent director of PNC Funds who served ...
Metropolitan West Asset Management was handed a victory in court this week, one that mutual fund industry litigators say could finally put an end to lawsuits ...
The time will soon be here to start preparing for third- and fourth-quarter board meetings, and for those boards overseeing smaller mutual fund complexes, the issues ...